Unit 5: Bioavailability, ADME, and Bioequivalence

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/71

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 10:07 PM on 4/16/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

72 Terms

1
New cards

What are the three core concepts in Unit 5?

ADME, Bioavailability, Bioequivalence.

2
New cards

Why are ADME, bioavailability, and bioequivalence important?

They determine how well a drug works, how quickly it acts, and whether products can be safely substituted.

3
New cards

What does ADME stand for?

Absorption, Distribution, Metabolism, Excretion.

4
New cards

What does ADME describe?

The journey of a drug through the body from administration to elimination.

5
New cards

What is absorption?

Movement of a drug from site of administration into the bloodstream.

6
New cards

Most oral drug absorption occurs where?

Small intestine (not stomach).

7
New cards

Factors affecting absorption?

Drug formulation, gastric pH, food, drug interactions.

8
New cards

Example of drug interaction reducing absorption?

Antacids reducing tetracycline absorption.

9
New cards

IV administration bioavailability?

100% (bypasses absorption).

10
New cards

Do topical drugs have high systemic absorption?

No, usually limited and act locally.

11
New cards

What is distribution?

Movement of drug from bloodstream into tissues and fluids.

12
New cards

Factors affecting distribution?

Blood flow, protein binding, lipid solubility.

13
New cards

Highly protein-bound drugs risk?

Drug displacement and toxicity.

14
New cards

Example of highly protein-bound drug?

Warfarin.

15
New cards

Lipid-soluble drugs tend to accumulate where?

Fatty tissue.

16
New cards

Water-soluble drugs remain where?

Bloodstream and extracellular fluid.

17
New cards

What is metabolism also called?

Biotransformation.

18
New cards

Primary organ of metabolism?

Liver.

19
New cards

Main enzyme system involved?

CYP450.

20
New cards

What is first-pass metabolism?

Liver metabolism before reaching systemic circulation.

21
New cards

What is a prodrug?

Drug requiring metabolic activation.

22
New cards

Example of prodrug?

Codeine → morphine.

23
New cards

CYP450 inhibitors effect?

Increase drug concentrations.

24
New cards

CYP450 inducers effect?

Decrease drug effectiveness.

25
New cards

Example CYP inhibitor?

Ketoconazole.

26
New cards

Example CYP inducer?

Rifampin, St. John’s Wort.

27
New cards

Primary route of excretion?

Kidneys (renal).

28
New cards

Other excretion routes?

Biliary, lungs.

29
New cards

What is enterohepatic recycling?

Drug reabsorbed from intestine prolonging effect.

30
New cards

Kidney impairment effect?

Drug accumulation and toxicity.

31
New cards

Define bioavailability.

Percentage of administered dose reaching systemic circulation in active form.

32
New cards

IV bioavailability?

100%.

33
New cards

Why is oral bioavailability lower?

Incomplete absorption + first-pass metabolism.

34
New cards

Routes partially bypassing first-pass?

Sublingual, transdermal, rectal.

35
New cards

Why is oral morphine dose higher than IV?

Extensive first-pass metabolism.

36
New cards

Bioavailability affects what?

Dosing.

37
New cards

Why must ER and IR not be interchanged?

Different absorption profiles.

38
New cards

Dosage form affects bioavailability how?

Immediate vs extended-release changes absorption rate.

39
New cards

Solubility effect?

Lipophilic drugs absorb more easily.

40
New cards

Food impact?

Can increase or decrease absorption.

41
New cards

Drug interaction example?

Calcium reduces tetracycline absorption.

42
New cards

Patient-specific factors?

age, disease state, liver function.

43
New cards

Define bioequivalence.

Two products deliver same amount of drug at same rate and extent.

44
New cards

Bioequivalence compares what?

Brand vs generic products.

45
New cards

FDA criteria for bioequivalence?

No significant difference in rate and extent of absorption.

46
New cards

Rate of absorption known as?

Cmax.

47
New cards

Extent of absorption known as?

AUC.

48
New cards

Does PTCB require Cmax/AUC memorization?

No, but understand rate and extent concepts.

49
New cards

Bioequivalence alone equals therapeutic equivalence?

No.

50
New cards

Requirements for therapeutic equivalence?

Pharmaceutical equivalence + bioequivalence + FDA standards.

51
New cards

Pharmaceutical equivalence means?

Same active ingredient, dosage form, and strength.

52
New cards

Orange Book purpose?

Lists therapeutic equivalence codes.

53
New cards

AB rating means?

Interchangeable.

54
New cards

BX rating means?

Not substitutable.

55
New cards

Why must digoxin be monitored?

Narrow therapeutic index; small bioavailability changes cause toxicity.

56
New cards

Why cautious with phenytoin generic switching?

Tight therapeutic margins.

57
New cards

Why is nitroglycerin not given orally?

First-pass metabolism.

58
New cards

Why must PPIs delayed-release be swallowed whole?

Protect bioavailability.

59
New cards

Why is levothyroxine not always interchangeable?

Small bioavailability differences destabilize thyroid levels.

60
New cards

Why is warfarin bioequivalence critical?

Over/under anticoagulation risk.

61
New cards

Why monitor cyclosporine brand vs generic?

Variability impacts transplant rejection risk.

62
New cards


Where does most oral absorption occur?
A. Stomach
B. Small intestine
C. Liver
D. Colon

B. Small intestine

63
New cards

Which route has 100% bioavailability?
A. Oral
B. Sublingual
C. IV
D. Rectal

C. IV

64
New cards

First-pass metabolism primarily occurs in the:
A. Kidneys
B. Lungs
C. Liver
D. Intestine

C. Liver

65
New cards

A CYP450 inhibitor will most likely:
A. Decrease drug levels
B. Increase drug levels
C. Prevent absorption
D. Increase excretion

B. Increase drug levels

66
New cards

AB rating in Orange Book means:
A. Not interchangeable
B. Brand only
C. Interchangeable
D. Experimental

C. Interchangeable

67
New cards

Which drug requires careful monitoring due to narrow therapeutic index?
A. Amoxicillin
B. Digoxin
C. Acetaminophen
D. Loratadine

B. Digoxin

68
New cards

A patient switches from immediate-release to extended-release without dose adjustment. What is the primary risk?
A. Faster onset
B. Reduced absorption variability
C. Altered bioavailability and toxicity
D. Increased excretion

C. Altered bioavailability and toxicity

69
New cards

A patient takes ciprofloxacin with antacids. What occurs?
A. Increased metabolism
B. Chelation reduces absorption
C. Increased protein binding
D. Faster excretion

B. Chelation reduces absorption

70
New cards

A highly protein-bound drug is added to warfarin therapy. What may happen?
A. Increased renal clearance
B. Displacement and bleeding risk
C. Decreased distribution
D. Reduced metabolism

B. Displacement and bleeding risk

71
New cards

A drug undergoes enterohepatic recycling. What is the clinical result?
A. Faster elimination
B. Reduced absorption
C. Prolonged drug effect
D. Increased renal toxicity

C. Prolonged drug effect

72
New cards

A generic product shows identical rate but lower extent of absorption compared to brand. Is it bioequivalent?
A. Yes
B. No

B. No